Berlin-Based Biotech Startup inne Secures $2.5 Million in Funding to Revolutionize Fertility Tracking for Women

We are thrilled to announce that inne, an innovative biotech startup based in Berlin, has successfully raised $2.5 million in funding to further enhance our mission of empowering women to track their fertility with unprecedented accuracy and convenience. At inne, we believe that understanding the female reproductive system is a powerful combination of beauty and logic, and we are committed to pushing the frontiers of science, technology, and design to reflect this perspective. Our groundbreaking approach utilizes biochemistry to enable women to monitor their hormone levels through a simple, flexible, 30-second at-home saliva test. This unique testing method not only predicts but also confirms ovulation by providing women with real-time insights into their hormone levels. With the new funding, we plan to further develop our user-friendly mobile application, which translates these hormone readings into comprehensible data, empowering women to make informed decisions about their fertility and overall health. Our goal is to create a seamless experience that fosters a deeper connection between women and their bodies, helping them tune into their natural rhythms. The investment will also support our research and development efforts, ensuring that we continue to stay at the forefront of fertility tracking technology. As we embark on this exciting journey, we invite women everywhere to join us in redefining the narrative around women's health and fertility, one empowered choice at a time. Thank you for believing in our vision and supporting our mission to transform how women understand and engage with their reproductive health.